伟思医疗业绩快报：2025年度归母净利润1.37亿元，同比增长33.99%

Core Viewpoint - The company reported a significant increase in both revenue and net profit for the fiscal year 2025, indicating strong financial performance and growth potential [1] Financial Performance - Total revenue for the year reached 463 million yuan, representing a year-on-year growth of 15.66% [1] - Net profit attributable to shareholders was 137 million yuan, showing a year-on-year increase of 33.99% [1] - Basic earnings per share were reported at 1.43 yuan [1]